1. Home
  2. VRAR vs CTXR Comparison

VRAR vs CTXR Comparison

Compare VRAR & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc.

VRAR

The Glimpse Group Inc.

HOLD

Current Price

$1.19

Market Cap

17.2M

Sector

Technology

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.84

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAR
CTXR
Founded
2016
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
16.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VRAR
CTXR
Price
$1.19
$0.84
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$2.62
$6.00
AVG Volume (30 Days)
172.5K
1.3M
Earning Date
02-12-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,488,209.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.00
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
16.60
N/A
52 Week Low
$0.77
$0.63
52 Week High
$2.05
$3.40

Technical Indicators

Market Signals
Indicator
VRAR
CTXR
Relative Strength Index (RSI) 59.98 40.13
Support Level $1.03 $0.74
Resistance Level $1.17 $0.99
Average True Range (ATR) 0.11 0.06
MACD 0.02 0.01
Stochastic Oscillator 81.08 32.71

Price Performance

Historical Comparison
VRAR
CTXR

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: